Products & Services

Our capabilities place AAHI at the intersection of emerging sciences, medicine, and the business of biotech, enabling us to provide technologies, services, and insights that advance the state-of-the art for the entire biomedical community.

AAHI provides custom vaccine and immunotherapy solutions  with next generation features and functionality, translating into unique products capable of addressing pressing global health needs.

AAHI is uniquely positioned to support development of products based on our immune-enhancing platforms from bench to clinic. Our partnerships with large pharmaceuticals enable collaborations to bring our products to market, providing accessibility around the world.

Learn more about AAHI’s adjuvant formulations by visiting the Adjuvant Catalogue

Learn more about AAHI’s RNA Vaccine delivery vehicle

AAHI Pipeline

AAHI’s adjuvant technology has been clinically tested in nearly 10,000 human volunteers and has an outstanding safety profile.

Adjuvant
Preclinical
GMP/Tox
Phase 1
Phase 2
Phase 3
Squalene Emulsion
SE
 
 
 
 
TLR 4 Agonists
 
 
 
 
GLA-AF/Alum
 
 
 
 
 
 
 
 
TLR/ 7/8 Agonists
 
 
 
 
 
 
 
 
TLR 4 Agonists + Saponin
 
 
 
 
 
 
 
 
Dual Agonist
 
 
 
 
RNA Delivery Vehicle
Preclinical
GMP/Tox
Phase 1
Phase 2
Phase 3
Nanostructured Lipid Carrier
NLC
 
 
 
 

Services

AAHI offers world-class expertise in the design, formulation, and manufacture of vaccines, adjuvants, immunotherapies, and their components.